How to Get NMN/NR (Nicotinamide Mononucleotide/Riboside) in South Carolina

NMN vs. NR: Two NAD+ Precursors, Two Regulatory Paths

NMN and NR both raise intracellular NAD+ levels, but they sit in different regulatory categories in the United States. That distinction determines how you access each one in South Carolina.

In November 2022, the FDA issued a determination that NMN could not be marketed as a dietary supplement because it was already under investigation as a new drug (by Metro International Biotech). This ruling removed NMN from retail supplement shelves at compliant retailers, though enforcement has been inconsistent. The practical result: pharmaceutical-grade NMN in South Carolina now flows primarily through 503A compounding pharmacies that fill patient-specific prescriptions.

NR (nicotinamide riboside), sold under brands like Niagen and Tru Niagen, was not subject to the same exclusion. It remains classified as a New Dietary Ingredient (NDI) with self-affirmed GRAS status. South Carolina residents can purchase NR supplements online or at retail without a prescription.

A 2021 randomized trial by Yoshino et al. (Science, 2021) demonstrated that 250 mg/day of NMN for 10 weeks improved skeletal muscle insulin signaling in postmenopausal women with prediabetes (N=25). Muscle insulin sensitivity, measured by the hyperinsulinemic-euglycemic clamp, increased by approximately 25% in the NMN group versus no change with placebo [1]. A separate 12-week RCT by Martens et al. (Nature Communications, 2018) found that NR supplementation at 1,000 mg/day reduced systolic blood pressure by 5.8 mmHg and aortic stiffness by 8.2% in healthy middle-aged and older adults (N=24) [2].

How Telehealth Prescribing Works for NMN in South Carolina

South Carolina allows synchronous telehealth visits to establish a provider-patient relationship, which means a licensed prescriber can evaluate you, order labs, and write an NMN prescription without an in-person office visit.

The South Carolina Board of Medical Examiners requires that the telehealth encounter use real-time audio-video communication. Phone-only consultations do not satisfy the standard of care for new prescriptions under SC Code § 40-47-37. Once the relationship is established, follow-up visits may use asynchronous messaging at the provider's discretion.

A typical telehealth workflow for NMN in South Carolina follows this sequence: you complete an intake form with medical history and current medications, the provider reviews your information and schedules a video consultation (usually 15 to 20 minutes), the provider orders baseline labs if you have not completed them recently, and after reviewing results, the provider sends a prescription to a 503A compounding pharmacy licensed in South Carolina. Most telehealth longevity platforms complete this process within 7 to 14 days from initial signup to prescription delivery.

The Endocrine Society's 2024 position statement on NAD+ precursors noted that "clinical evidence for NMN and NR remains early-stage, and prescribing decisions should weigh the limited trial data against patient goals and risk tolerance." This framing matters. Your telehealth provider should discuss what NMN can and cannot do based on current evidence before writing the prescription.

Who Can Prescribe NMN in South Carolina

Three categories of licensed clinicians in South Carolina can prescribe compounded NMN: physicians (MD/DO), nurse practitioners (NP), and physician assistants (PA). The scope differs.

MDs and DOs have full prescriptive authority and can prescribe NMN without supervisory restrictions. NPs in South Carolina practice under a collaborative agreement with a physician, per SC Code § 40-33-34. An NP can prescribe NMN as long as the collaborative agreement covers the prescriber's scope and the supervising physician does not exclude it. PAs similarly require a supervisory relationship with a physician, documented in a scope-of-practice agreement filed with the SC Board of Medical Examiners.

In practice, most telehealth longevity platforms employ MDs or DOs to avoid the administrative complexity of collaborative agreements. If you see an NP or PA through a telehealth service, confirm that their collaborative agreement explicitly permits prescribing compounded supplements or longevity agents.

503A Compounding Pharmacies and South Carolina Shipping

The distinction between 503A and 503B pharmacies matters for how you receive NMN in South Carolina.

A 503A pharmacy compounds medications in response to individual patient prescriptions. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, these pharmacies may compound NMN for a specific patient when a licensed prescriber writes the order. South Carolina's Board of Pharmacy licenses in-state 503A pharmacies and also permits out-of-state 503A pharmacies to ship into SC, provided they hold a nonresident pharmacy license.

A 503B outsourcing facility operates under FDA registration and can produce compounded medications in larger batches without patient-specific prescriptions. However, very few 503B facilities currently produce NMN, so the 503A route remains the primary channel for South Carolina patients.

Shipping timelines vary. Most 503A pharmacies compound NMN capsules or sublingual tablets to order, which takes 3 to 5 business days for preparation plus 2 to 5 business days for shipping. Cold-chain sublingual formulations may require expedited shipping at additional cost. Expect a total turnaround of 5 to 10 business days from the pharmacy receiving the prescription to delivery at your South Carolina address.

Pricing without insurance (since neither Medicaid nor most commercial plans cover NMN) typically ranges from $80 to $180 per month for 250 to 500 mg daily oral capsules. Sublingual formulations tend to cost 15% to 30% more due to additional compounding steps.

What Labs Should You Get Before Starting NMN

Baseline laboratory testing serves two purposes: it rules out conditions that might make NAD+ precursor supplementation inappropriate, and it establishes reference values so your provider can track response over time.

A reasonable pre-NMN lab panel includes a comprehensive metabolic panel (CMP) to assess liver and kidney function, a complete blood count (CBC), a fasting lipid panel, fasting glucose and HbA1c, and if available, a whole-blood NAD+ level or NAD+ metabolome panel. The NAD+ metabolome test, offered by specialty labs like Jinfiniti, measures intracellular NAD+ and related metabolites. It costs approximately $150 to $250 out of pocket and is not covered by insurance in South Carolina.

A 2022 systematic review in Aging Cell examining 17 human trials of NAD+ precursors found that NMN and NR were generally well tolerated, with no serious adverse events reported across studies ranging from 2 to 12 weeks [3]. Liver enzyme elevations were not observed at doses up to 1,200 mg/day of NR or 1,250 mg/day of NMN. Still, checking baseline hepatic function is standard practice for any new supplement protocol, and the American Association of Clinical Endocrinology (AACE) recommends metabolic screening before initiating longevity-focused therapies.

Most telehealth providers recheck labs at 8 to 12 weeks after starting NMN, then every 6 months if values remain stable.

South Carolina Medicaid and Insurance Coverage

South Carolina Medicaid does not cover NMN or NR. This applies to both fee-for-service Medicaid and managed care organizations (MCOs) like Healthy Blue, Molina Healthcare of South Carolina, and Absolute Total Care.

Commercial insurers in South Carolina (BlueCross BlueShield of South Carolina, Cigna, Aetna, UnitedHealthcare) similarly exclude NAD+ precursors from formulary coverage. The reason is straightforward: NMN has no FDA-approved indication, and NR is classified as a dietary supplement. Without a National Drug Code (NDC) tied to an approved New Drug Application (NDA), insurers have no reimbursement pathway.

Prior authorization is not applicable here because there is no coverage to authorize. If a telehealth provider mentions submitting a prior authorization for NMN, that is a red flag. The correct expectation is full out-of-pocket payment.

Some patients use Health Savings Account (HSA) or Flexible Spending Account (FSA) funds to pay for compounded NMN. The IRS permits HSA/FSA reimbursement for prescription medications, and a compounded NMN prescription from a licensed provider may qualify. Confirm with your HSA/FSA administrator, as interpretations vary.

Choosing Between NMN and NR in South Carolina

The decision between prescription NMN and over-the-counter NR depends on your clinical goals, budget, and tolerance for regulatory ambiguity.

NR is simpler to obtain. No prescription, no telehealth visit, no compounding pharmacy. Tru Niagen (300 mg NR per capsule) is widely available online and at South Carolina retail locations including CVS, Walgreens, and Walmart. A 30-day supply at 300 mg/day costs approximately $40 to $50.

NMN requires the prescription pathway described above but offers a different pharmacokinetic profile. NMN is one enzymatic step closer to NAD+ in the salvage pathway (NMN is converted directly to NAD+ by NMNAT enzymes, while NR must first be phosphorylated to NMN by NR kinases). Whether this translates to clinically meaningful differences in NAD+ elevation remains unresolved. A pharmacokinetic study by Airhart et al. (PLOS ONE, 2017) showed that NR at 1,000 mg/day increased whole-blood NAD+ by approximately 100% over 8 days in healthy volunteers (N=8), confirming bioavailability [4]. Comparable human PK data for NMN has been reported by Igarashi et al. (N Engl J Med, 2022), showing dose-dependent NAD+ increases with oral NMN up to 1,250 mg/day [5].

Dr. Charles Brenner, who discovered the NR kinase pathway, has stated publicly that "NR and NMN are both converted to NAD+ through overlapping but non-identical enzymatic routes, and head-to-head clinical trials comparing the two are needed before claims of superiority can be made" [6].

For South Carolina residents who want clinical oversight, lab monitoring, and pharmaceutical-grade product, the NMN-via-telehealth-plus-503A route is appropriate. For those who prefer convenience, lower cost, and a supplement they can buy today, NR is the pragmatic choice.

Dose Forms and Protocols Used in South Carolina

Most 503A pharmacies compounding NMN for South Carolina patients offer two primary dose forms: oral capsules and sublingual tablets.

Oral capsules are the most common. Standard doses range from 250 mg to 500 mg once daily, taken in the morning with or without food. The Yoshino et al. trial used 250 mg/day and observed metabolic improvements at that dose [1]. Some longevity-focused clinicians prescribe 500 mg to 1,000 mg daily for patients with documented low baseline NAD+ levels, though dose-response data from large RCTs supporting doses above 250 mg remain limited.

Sublingual tablets dissolve under the tongue and bypass first-pass hepatic metabolism. Proponents argue this produces faster absorption and higher peak NAD+ levels, but published human pharmacokinetic comparisons between oral and sublingual NMN are sparse. Sublingual tablets typically come in 125 mg or 250 mg strengths, dosed once or twice daily.

A less common option is NMN nasal spray, compounded by a small number of 503A pharmacies. Clinical data on intranasal NMN bioavailability in humans is essentially nonexistent, so this route should be considered experimental.

Your prescribing clinician should select the dose form based on your goals, baseline NAD+ levels if measured, and any GI tolerance issues. The standard starting protocol is 250 mg oral NMN once daily for 8 weeks, followed by lab reassessment and potential dose adjustment.

Safety Profile and Drug Interactions

Published human safety data for NMN and NR is reassuring but limited in duration. The longest published NMN trial ran 12 weeks. No serious adverse events were reported across any published human NMN or NR study through 2025.

Common mild side effects reported in trials include flushing (particularly with higher NR doses above 1,000 mg/day, likely due to conversion to niacin metabolites), mild GI discomfort (nausea, bloating), and headache in the first week of use. These effects are typically self-limiting.

Theoretical drug interactions deserve mention. NAD+ influences sirtuin and PARP enzyme activity, which play roles in DNA repair and metabolic regulation. Patients taking PARP inhibitors (olaparib, rucaparib, niraparib) for BRCA-mutated cancers should not take NMN or NR without oncologist approval, as raising NAD+ levels could theoretically reduce PARP inhibitor efficacy. This concern is based on mechanistic reasoning from preclinical data published in Cancer Discovery (2020) rather than human clinical evidence, but the potential interaction is biologically plausible [7].

Patients on immunosuppressants should also discuss NMN with their prescriber, as NAD+ metabolism intersects with immune cell function. The NIH Office of Dietary Supplements fact sheet on niacin-related compounds provides a reference framework for clinicians evaluating these interactions [8].

How to Transfer an Existing NMN Prescription to South Carolina

If you have an active NMN prescription from a provider in another state, transferring it to a South Carolina pharmacy follows standard prescription transfer rules with one important caveat: NMN is a compounded medication, so both the sending and receiving pharmacies must be 503A-licensed.

The process works as follows. Contact the South Carolina 503A pharmacy where you want to fill the prescription. Provide them with the name and contact information of your current pharmacy. The receiving pharmacist will initiate the transfer by contacting the sending pharmacy directly. South Carolina Board of Pharmacy regulations permit prescription transfers between licensed pharmacies, including nonresident pharmacies licensed to operate in SC.

If your original prescriber is not licensed in South Carolina, you may need a new prescription from an SC-licensed provider. Telehealth makes this simple. Most longevity telehealth platforms can review your existing records and reissue a prescription within one to two business days.

One note on continuity: compounding formulations vary between pharmacies. The NMN capsule you received from a pharmacy in North Carolina or Georgia may differ in excipients, filler, and potentially bioavailability from what a South Carolina 503A pharmacy compounds. Discuss any formulation changes with your prescriber so they can adjust monitoring accordingly.

What South Carolina Residents Should Know About Quality and Testing

Compounded NMN is not subject to the same manufacturing standards as FDA-approved drugs. A 503A pharmacy follows USP Chapter 795 (nonsterile compounding) guidelines, which require quality controls but permit more variability than cGMP manufacturing.

Ask your 503A pharmacy whether they perform third-party certificate of analysis (COA) testing on their NMN bulk powder. Reputable pharmacies source NMN from suppliers that provide COAs showing purity (typically >98% by HPLC), heavy metals testing, and microbial limits testing. If the pharmacy cannot provide a COA on request, consider a different source.

For NR supplements purchased over the counter, look for products carrying NSF International or USP Verified marks. Tru Niagen holds an Informed Sport certification and publishes third-party testing results. A 2023 analysis published in Nutrients tested 22 commercially available NAD+ precursor supplements and found that 27% contained less NMN or NR than labeled [9]. Third-party verification is not optional.

The standard starting dose for prescription NMN in South Carolina remains 250 mg oral once daily, reassessed at 8 to 12 weeks with repeat NAD+ metabolome testing and a basic metabolic panel [1].